Search

Weilenmann, Daniel
 
Advanced search
Browse by...
Refine your research by the most used items

Author / Editor

Document type

Full text accessibility

Full text version

Licence

Subject

Deposit
Highlights
More informations
Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
 Five-year outcomes with Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in patients with Acute Coronary Syndrome: A subgroup analysis of the BIOSCIENCE Trial Iglesias, Juan Fernando; Heg, Dik; Roffi, Marco; Degrauwe, Sophie; ... Pilgrim, Thomas 2022
add to browser selection
 Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial Iglesias, Juan Fernando; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; ... Pilgrim, Thomas 2021
add to browser selection
 Biodegradable-Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial Pilgrim, Thomas; Muller, Olivier; Heg, Dik; Roffi, Marco; ... Iglesias, Juan Fernando 2021
add to browser selection
 Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial Iglesias, Juan Fernando; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; ... Pilgrim, Thomas 2020
add to browser selection
 Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial Iglesias, Juan Fernando; Muller, Olivier; Heg, Dik; Roffi, Marco; ... Pilgrim, Thomas 2019
add to browser selection
 Long-term data from the Swiss pulmonary hypertension registry Mueller-Mottet, Séverine; Stricker, Hans; Domeninghetti, Guido; Azzola, Andréa; ... Ulrich, Silvia 2015